PSUSA/00002204/202404
Submitted by Anonymous (not verified) on 2 December 2024 - 16:18
PSUSA/00002204/202404
Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 2 December 2024 - 16:14
Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 3, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prevexxion RN+HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 2 December 2024 - 14:59
Veterinary medicines European public assessment report (EPAR): Prevexxion RN+HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Metacam, meloxicam, Status: Authorised
Submitted by Anonymous (not verified) on 2 December 2024 - 14:51
Veterinary medicines European public assessment report (EPAR): Metacam, meloxicam, Status: Authorised
Human medicines European public assessment report (EPAR): Sancuso, granisetron, Date of authorisation: 20/04/2012, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 2 December 2024 - 14:47
Human medicines European public assessment report (EPAR): Sancuso, granisetron, Date of authorisation: 20/04/2012, Revision: 15, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Frontpro (previously Afoxolaner Merial), afoxolaner, Date of authorisation: 20/05/2019, Status: Authorised
Submitted by Anonymous (not verified) on 2 December 2024 - 14:46
Veterinary medicines European public assessment report (EPAR): Frontpro (previously Afoxolaner Merial), afoxolaner, Date of authorisation: 20/05/2019, Status: Authorised
Committee for Advanced Therapies (CAT): 4-6 December 2024, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2024 to 6 December 2024
Submitted by Anonymous (not verified) on 2 December 2024 - 12:36
Committee for Advanced Therapies (CAT): 4-6 December 2024, European Medicines Agency, Amsterdam, the Netherlands, from 4 December 2024 to 6 December 2024
Agenda of the CAT meeting 4-6 December 2024
Submitted by Anonymous (not verified) on 2 December 2024 - 12:33
Agenda of the CAT meeting 4-6 December 2024
Abbreviations used in EMA scientific committees and CMD documents, and in relation to EMA’s regulatory activities
Submitted by Anonymous (not verified) on 2 December 2024 - 11:12
Abbreviations used in EMA scientific committees and CMD documents, and in relation to EMA’s regulatory activities
QRD veterinary Appendix I - Adverse event (PhV) MSs reporting details
Submitted by Anonymous (not verified) on 2 December 2024 - 10:37
QRD veterinary Appendix I - Adverse event (PhV) MSs reporting details